Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) posted its earnings results on Tuesday. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.89 by $0.07, FiscalAI reports. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The firm had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies’s revenue was up 6.2% on a year-over-year basis.
Here are the key takeaways from Marsh & McLennan Companies’ conference call:
- Marsh reported a solid second quarter, with revenue up 6%, underlying growth up 5%, adjusted operating income up 5%, and adjusted EPS up 9% year over year.
- Management said demand remains strong and raised confidence in the full-year outlook, reiterating expectations for similar underlying growth to 2025, another year of margin expansion, and solid adjusted EPS growth.
- Marsh Risk performed well despite pricing pressure, with U.S. and Canada underlying growth accelerating to 4% and international growth holding at 5%, driven by strong new business and broader talent hiring.
- Guy Carpenter continued to face a difficult reinsurance backdrop, as revenue fell 2% and management cited steep property catastrophe pricing declines as a major drag on growth.
- The company highlighted progress in its Thrive strategy, including brand consolidation, AI tools, and sales-capacity investments, and it expects to deliver $400 million of savings while deploying about $5.5 billion of capital in 2026.
Marsh & McLennan Companies Price Performance
Shares of MRSH opened at $176.27 on Thursday. Marsh & McLennan Companies has a one year low of $156.60 and a one year high of $213.80. The stock has a market capitalization of $85.16 billion, a P/E ratio of 21.55, a price-to-earnings-growth ratio of 2.73 and a beta of 0.61. The company has a quick ratio of 1.11, a current ratio of 1.14 and a debt-to-equity ratio of 1.22.
Marsh & McLennan Companies Increases Dividend
Insider Activity
In related news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.38% of the company’s stock.
Institutional Trading of Marsh & McLennan Companies
Several hedge funds and other institutional investors have recently bought and sold shares of MRSH. Swiss Life Asset Management Ltd boosted its position in Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock worth $24,960,000 after acquiring an additional 11,648 shares during the period. Essex LLC acquired a new position in shares of Marsh & McLennan Companies in the 1st quarter valued at about $2,891,000. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Marsh & McLennan Companies by 20.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 88,934 shares of the financial services provider’s stock worth $16,499,000 after purchasing an additional 15,166 shares during the period. Vanguard Group Inc. grew its position in Marsh & McLennan Companies by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 46,589,633 shares of the financial services provider’s stock valued at $8,643,309,000 after purchasing an additional 387,100 shares in the last quarter. Finally, Benjamin Edwards Inc. increased its stake in Marsh & McLennan Companies by 26.6% in the 4th quarter. Benjamin Edwards Inc. now owns 35,293 shares of the financial services provider’s stock valued at $6,549,000 after buying an additional 7,418 shares during the period. 87.99% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have issued reports on MRSH. Weiss Ratings downgraded shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Piper Sandler reduced their target price on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Citigroup downgraded Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price target for the company. in a report on Wednesday. Mizuho boosted their price objective on Marsh & McLennan Companies from $197.00 to $201.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Morgan Stanley dropped their target price on Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating on the stock in a report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $201.69.
Read Our Latest Research Report on MRSH
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- Thematic Memory ETFs Give Investors a New Way to Play AI’s Hidden Bottleneck
- Rocket Lab Has Corrected Nearly 50%. Is It Still Too Expensive?
- Cybersecurity ETFs Are Rallying While AI Stocks Cool Off
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
